Tauriga Sciences Stock Shares Outstanding
Tauriga Sciences fundamentals help investors to digest information that contributes to Tauriga Sciences' financial success or failures. It also enables traders to predict the movement of Tauriga OTC Stock. The fundamental analysis module provides a way to measure Tauriga Sciences' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Tauriga Sciences otc stock.
Tauriga |
Tauriga Sciences OTC Stock Shares Outstanding Analysis
Tauriga Sciences' Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current Tauriga Sciences Shares Outstanding | 299.91 M |
Most of Tauriga Sciences' fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Tauriga Sciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
CompetitionBased on the latest financial disclosure, Tauriga Sciences has 299.91 M of shares currently outstending. This is 66.12% higher than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—Specialty & Generic industry. The shares outstanding for all United States stocks is 47.55% higher than that of the company.
Tauriga Shares Outstanding Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Tauriga Sciences' direct or indirect competition against its Shares Outstanding to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Tauriga Sciences could also be used in its relative valuation, which is a method of valuing Tauriga Sciences by comparing valuation metrics of similar companies.Tauriga Sciences is currently under evaluation in shares outstanding category among its peers.
Tauriga Fundamentals
| Return On Equity | -63.19 | |||
| Return On Asset | -1.72 | |||
| Operating Margin | (17.15) % | |||
| Current Valuation | 519.42 K | |||
| Shares Outstanding | 299.91 M | |||
| Shares Owned By Insiders | 3.38 % | |||
| Price To Earning | 1.82 X | |||
| Price To Book | 6.60 X | |||
| Price To Sales | 0 X | |||
| Revenue | 285.32 K | |||
| Gross Profit | 122.69 K | |||
| EBITDA | (2.53 M) | |||
| Net Income | (3.63 M) | |||
| Cash And Equivalents | 1.02 M | |||
| Total Debt | 1.51 M | |||
| Debt To Equity | 0.85 % | |||
| Current Ratio | 0.68 X | |||
| Book Value Per Share | (0) X | |||
| Cash Flow From Operations | (2.55 M) | |||
| Earnings Per Share | (0.02) X | |||
| Target Price | 0.1 | |||
| Beta | 1.94 | |||
| Market Capitalization | 299 | |||
| Total Asset | 2.49 M | |||
| Retained Earnings | (53.26 M) | |||
| Working Capital | (2.96 M) | |||
| Current Liabilities | 2.96 M | |||
| Z Score | -33.9 | |||
| Net Asset | 2.49 M |
About Tauriga Sciences Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Tauriga Sciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Tauriga Sciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Tauriga Sciences based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in employment. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Consideration for investing in Tauriga OTC Stock
If you are still planning to invest in Tauriga Sciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Tauriga Sciences' history and understand the potential risks before investing.
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |